We are live on
!
Find out more
TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.7B
1-Year Est. Return
6.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.03%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$5.95B
AUM Growth
-$480M
(-7.5%)
Cap. Flow
-$535M
Cap. Flow
% of AUM
-8.99%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
414
New
33
Increased
111
Reduced
196
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$36.8M |
| 2 |
AMTM
Amentum Holdings
AMTM
|
+$28.1M |
| 3 |
U-Haul Holding Co Series N
UHAL.B
|
+$27.4M |
| 4 |
Zimmer Biomet
ZBH
|
+$20.7M |
| 5 |
HF Sinclair
DINO
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$64.5M |
| 2 |
National Fuel Gas
NFG
|
+$51.8M |
| 3 |
Ryanair
RYAAY
|
+$43.1M |
| 4 |
Liberty Global Class C
LBTYK
|
+$34.8M |
| 5 |
Labcorp
LH
|
+$34.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.96% |
| 2 | Industrials | 13.89% |
| 3 | Consumer Staples | 10.87% |
| 4 | Technology | 10.61% |
| 5 | Financials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
iShares MSCI EAFE ETF
EFA
$78.4B
| $5.58M | 0.09% |
68,289
-799,897
| -92% | -$64.5M |
|
|
SCHW
177
Charles Schwab
SCHW
$184B
| $5.55M | 0.09% |
70,932
-16,157
| -19% | -$1.27M |
|
178
Compass Minerals
CMP
$1.2B
| $5.51M | 0.09% |
592,652
-56,620
| -9% | -$646K |
|
179
Casey's General Stores
CASY
$32B
| $5.47M | 0.09% |
12,602
-205
| -2% | -$84K |
|
180
Guidewire Software
GWRE
$13.1B
| $5.38M | 0.09% |
28,700
+5,700
| +25% | +$1.11M |
|
181
Roivant Sciences
ROIV
$24B
| $5.38M | 0.09% |
532,764
-32,573
| -6% | -$352K |
|
182
Target
TGT
$68B
| $5.36M | 0.09% |
51,309
-25,063
| -33% | -$3.13M |
|
183
Adeia
ADEA
$3.03B
| $5.34M | 0.09% |
404,283
-242,237
| -37% | -$3.37M |
|
184
AdvanSix
ASIX
$541M
| $5.34M | 0.09% |
235,841
-4,890
| -2% | -$136K |
|
185
Norfolk Southern
NSC
$75.1B
| $5.12M | 0.09% |
21,619
-525
| -2% | -$128K |
|
186
BGC Group
BGC
$5.41B
| $5.12M | 0.09% |
557,911
-144,295
| -21% | -$1.35M |
|
187
FedEx
FDX
$73.1B
| $5.1M | 0.09% |
20,912
+218
| +1% | +$56.5K |
|
188
Morgan Stanley
MS
$330B
| $5.06M | 0.09% |
43,372
-11,261
| -21% | -$1.45M |
|
189
Banc of California
BANC
$3.05B
| $4.91M | 0.08% |
+345,895
| New | +$5.23M |
|
190
Baker Hughes
BKR
$60.1B
| $4.9M | 0.08% |
111,396
-800
| -0.7% | -$35.7K |
|
191
Solventum
SOLV
$15.1B
| $4.89M | 0.08% |
64,362
-47,575
| -43% | -$3.54M |
|
192
Travelers Companies
TRV
$77.9B
| $4.87M | 0.08% |
18,420
| – | – |
|
193
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $4.87M | 0.08% |
97,489
+5,203
| +6% | +$255K |
|
194
Chipotle Mexican Grill
CMG
$47B
| $4.84M | 0.08% |
96,380
+1,980
| +2% | +$108K |
|
195
SPDR Gold Trust
GLD
$131B
| $4.82M | 0.08% |
16,713
-396
| -2% | -$105K |
|
196
Vanguard Russell 1000 Growth ETF
VONG
$43.8B
| $4.79M | 0.08% |
51,583
-1,141
| -2% | -$116K |
|
197
Wells Fargo
WFC
$264B
| $4.76M | 0.08% |
66,337
-6,028
| -8% | -$453K |
|
198
Duke Energy
DUK
$96.7B
| $4.66M | 0.08% |
38,219
| – | – |
|
199
Extreme Networks
EXTR
$3.92B
| $4.55M | 0.08% |
343,717
+35,388
| +11% | +$554K |
|
200
Copart
CPRT
$27B
| $4.54M | 0.08% |
80,232
+985
| +1% | +$55.4K |
|
Similar funds
PI
ACM
VH
O
XT
DCP
HW
AAM
Thompson Siegel & Walmsley's Q1 2025 Portfolio in Review
As of Q1 2025, Thompson Siegel & Walmsley held 414 positions worth $5.95B, down 7.5% from $6.43B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Thompson Siegel & Walmsley withdrew a net $535M in Q1 2025, closing 29 positions and reducing 196 holdings. Its most notable exit was Ryanair, an estimated $43.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Thompson Siegel & Walmsley opened a new position in Biogen worth $35.2M.
- Thompson Siegel & Walmsley's largest Q1 2025 buy was Biogen: 257,456 shares worth $35.2M.
- Thompson Siegel & Walmsley added most to Amentum Holdings in Q1 2025, an estimated $28.1M increase.
- Thompson Siegel & Walmsley's biggest Q1 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $64.5M.
- Thompson Siegel & Walmsley fully exited Ryanair in Q1 2025, selling an estimated $43.1M.
- Thompson Siegel & Walmsley's ten largest holdings make up 18% of its $5.95B portfolio in Q1 2025.
- Thompson Siegel & Walmsley opened 33 new positions and closed 29 in Q1 2025.
- Thompson Siegel & Walmsley's portfolio value fell 7.5% quarter-over-quarter to $5.95B.
Based on Thompson Siegel & Walmsley's 13F filing for Q1 2025, filed 9 May 2025.